# A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide

> **NCT02222480** · PHASE2 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 103 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Fimasartan
- **DRUG:** Hydrochlorothiazide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02222480
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-05
- **Final completion:** 2015-06
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2016-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02222480

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02222480, "A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimasartan/Hydrochlorothiazide". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT02222480. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*